<?xml version="1.0" encoding="UTF-8"?>
<p id="para250">Lenalidomide dose reductions due to adverse reactions were allowed. Treatment was discontinued for grade 3 or 4 neutropenia and for a platelet count of less than 30 × 10
 <sup>9</sup>/L. On recovery, treatment was restarted at the previous dose, with the addition of granulocyte colony-stimulating factor in the case of grade 3 neutropenia with fever or grade 4 neutropenia. If neutropenia or thrombocytopenia occurred a second time, then the dose was reduced by one dose level as stipulated in the protocol (eg, from 10 mg daily to 5 mg daily). Full details of the dose reduction schedules are shown in the protocol (
 <xref rid="sec1" ref-type="sec">appendix p 34</xref>).
</p>
